Type | State university |
---|---|
Established | 2014 |
Parent institution | University of Milan (UNIMI) |
Location | , Italy |
Campus | Laboratorio Interdisciplinare Tecnologie Avanzate (LITA) (administrative headquarters and classrooms), Segrate; University of Milan, Italy (classrooms, teaching laboratories, and clinical sites) |
Language | English (lectures), Italian (clerkships) |
Programme Coordinator | Prof. Anna Marozzi |
Nickname | IMS UNIMI |
Website | ims |
The International Medical School (IMS) of the faculty of medicine of the University of Milan is a public English-language medical school located primarily in Milan and neighboring Segrate, Italy, with other teaching clinics in the Milan metropolitan area. [1] The school is officially recognized on the United Nations World Directory of Medical Schools. [2] It is consistently ranked as one of the top 100 medical schools in the world. [3] Its mission is to "provide graduates with both a solid, up-to-date scientific understanding of medicine, and a deep appreciation of the human and social complexities associated with health and disease.” [4]
The course was founded in 2010 as "MiMed" in Humanitas Hospital, as a combined effort of the University of Milan and the hospital. In 2014 the hospital opened its own private course, thus the university renamed the course as "International Medical School" and relocated it in L.I.T.A. (Laboratorio Interdisciplinare Tecnologie Avanzate) building in Segrate.
Admission to the school is dependent on a high score on the International Medical Admissions Test. Only the top 2% of test takers are admitted into the program. One-third of seats are reserved for students who are not citizens of the European Union, nor certain affiliated states, such as Switzerland and Norway. Among the incoming class of 2015, less than half the students were Italian citizens. [5] The minimum International Medical Admissions Test score for first-round entry among EU-applicants was 50.1, representing approximately the top 2% of test-takers. [6] Tuition ranges from about €800 to €4060 per year. [7]
The school has a six-year program. The curriculum is block/module based rather than course based, following a similar format as American and Canadian Medical Schools. The first two years are dedicated to pre-clinical studies, focusing on anatomy, physiology, biochemistry, and microbiology. [8] The following four years are clinical, with frequent rotations in different medical and surgical departments in hospitals. The school emphasizes problem-based learning, interdisciplinarity, and translational medicine. Students have the opportunity to do part of their education abroad via the Erasmus Programme. All teaching is in English. Students are required to learn Italian, [1] and, in order to be graduated, must, in English, write and defend a final thesis. [9] The degree granted is a Dottore magistrale, styled in English as a Doctor of Medicine. [10] [11]
The first two years are mostly held in L.I.T.A, being considered "preclinical". Besides lectures, activities (e.g. Problem-Based Learning, classes with anatomical models, spirometry tests etc.) are provided to improve knowledge of critical topics. From the third year onwards the students alternate between lectures and practical clinical learning in hospitals.
Among the school's teaching hospitals, there are:
The University of Milan, officially abbreviated as UNIMI, or colloquially referred to as La Statale, is a public research university in Milan, Italy. It is one of the largest universities in Europe, with about 60,000 students, and a permanent teaching and research staff of about 2,000.
Casa Sollievo della Sofferenza is a private scientific research hospital in San Giovanni Rotondo, Italy, founded by Saint Pio of Pietrelcina, and administered by Vatican City. Inaugurated on 5 May 1956, the hospital has adopted modern technologies and is often considered as one of the most efficient scientific research hospitals in Europe. The building is situated at the highest part of the town, on the top of the hill, giving the location an identity of a hospital-town. Casa Sollievo della Sofferenza has two major activity wings. One of which is an internationally regarded hospital for the relief of suffering and the other is a state-of-the-art scientific research centre which had received the status of a Scientific Hospitalization and Treatment Institute (IRCCS), an institute of national interest, by the decree of Italian Ministry of Health in 1991. The research centre is also home to the Genomic and Genetic Disorders Biobank which is part of the Telethon Network of Genetic Biobanks and conducts basic and pre-clinical research and clinical trials in collaboration with pharmaceutical companies. It is first in the world to run non-profit clinical trials. The hospital has established Institute for Stem-cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT) that will be the first factory of GMP neural stem cells in Europe for producing bio-drugs and cell-drugs. ISBReMIT has a dedicated area for the start-ups and spin-offs in biotechnology. Casa Sollievo della Sofferenza also houses a large out-patient clinic, a hospital-school for the children suffering from cancer and other genetic disorders, a reception centre which is a hotel complex, and a social-assistance residence for elderly. Casa Sollievo della Sofferenza also owns two agricultural companies-Masseria Calderoso and Posta La Via. It also hosts one spiritual centre, prayer group and a church. In front of Casa Sollievo della Sofferenza there is Sanctuary of Saint Pio of Pietrelcina, named after the founder of this hospital and research centre. In 2023, it was featured on the list of World's Best Smart Hospitals 2023.
The San Raffaele Hospital is a university hospital situated in Segrate, the Province of Milan, Italy. It was founded in 1969 by don Luigi Maria Verzé, president of "San Raffaele del Monte Tabor Foundation". The facility is connected to the Milan Metro by the MeLA people mover.
Università Cattolica del Sacro Cuore is an Italian private research university founded in 1921. Its main campus is located in Milan, Italy, with satellite campuses in Brescia, Piacenza, Cremona and Rome.
The Policlinico of Milan also known as Ospedale Maggiore di Milano or Ca' Granda Ospedale Maggiore Policlinico, is the public district general hospital in Milan, It is one of the oldest hospitals in Italy, founded by Duke Francesco Sforza in 1456. Today it is a modern hospital with 900 beds, with wards for adults, pregnant women and children. During the first COVID-19 breakout in March 2020, 300 of those beds were readapted for COVID-19 patients.
Giovanni Battista Monteggia was an Italian surgeon. The Monteggia fracture is named after him.
The Sant’Orsola-Malpighi Polyclinic is a public research hospital and district general hospital in Bologna. Sant’Orsola-Malpighi Polyclinc is the largest district general hospital in Italy, and the first of the four public hospitals of the city of Bologna.
Ospedale Niguarda Ca' Granda, best known simply as Ospedale Niguarda or Niguarda Hospital is largest and one of the most important hospitals in Milan, Italy.
Gianfelice Mario Rocca is an Italian billionaire businessman. He is chairman of the Techint Group and Istituto Clinico Humanitas.
The Istituto Giannina Gaslini is the biggest pediatric hospital of North Italy, located in Genoa Quarto dei Mille and founded by the Italian industrialist, politician and philanthropist Gerolamo Gaslini in 1938.
The Zone 9 of Milan, since 2016 officially Municipality 9 of Milan, is one of the 9 administrative divisions of Milan, Italy.
Policlinico San Matteo, known as Fondazione IRCCS Policlinico San Matteo, founded in 1449, is one of the oldest and largest teaching hospitals in Italy. It is located in the city of Pavia, about 35 km south of Milan. The hospital has over 3,300 physicians, as well as more than 1,000 beds. In 2016, the hospital handles 36,500 admissions, 13.7% of those are from outside Pavia, 99,000 admissions to the emergency department and 2.1 million outpatient services.
The following outline is provided as an overview of and topical guide to Milan:
The Organisation of European Cancer Institutes (OECI) is an international non-profit organization with European Economic Interest Grouping status. It was created in 1979 to promote greater cooperation among European cancer centers and institutes. Its head office is located in Brussels at the Belgian University Foundation.
Milano Innovation District (MIND) is the name given to the project dedicated to the area where Expo 2015 took place in Milan.
AmadeoLab is an Italian research institute based in Milan, Italy. The lab is a public hospital, currently representing the headquarters of the IRCCS National Cancer Institute (INT). and of the Neurological Institute "Carlo Besta". The building is made up of seven floors which contain all the medical, administrative and research departments. The Institute performs tests to prevent and diagnose potential oncological illnesses, and provides appropriate medical care and assistance for their treatment.
Alberto Priori is an Italian neurologist, academic, and author. He is a Professor of Neurology at the University of Milan, Director of Neurology 1 Unit at San Paolo Hospital, and the Founder and Coordinator of Aldo Ravelli Center of the University of Milan. He also serves as President of the Neurophysiopatology Techniques Course, and Professor of Postgraduate Schools - Medicine, Healthcare, Dental Medicine at the same University.